JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hynninen, M.
Right arrow Articles by Cheng, D. C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hynninen, M.
Right arrow Articles by Cheng, D. C. H.
Related Collections
Right arrow Surgery
Right arrow Heart
Anesth Analg 2001;92:810-816
© 2001 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

The Effect of Insulin Cardioplegia on Atrial Fibrillation After High-Risk Coronary Bypass Surgery: A Double-Blinded, Randomized, Controlled Trial

Marja Hynninen, MD*, Michael A. Borger, MD{dagger}, Vivek Rao, MD, PhD{dagger}, Richard D. Weisel, MD{dagger}, George T. Christakis, MD§, Jo-Ann Carroll, RN*, and Davy C. H. Cheng, MD*

*Division of Cardiac Anesthesia and Intensive Care, and {dagger}Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; and §Division of Cardiovascular Surgery, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada

Address correspondence and reprint requests to Davy Cheng, MD, Division of Cardiac Anesthesia and Intensive Care, Toronto General Hospital, University Health Network, 200 Elizabeth Street, EN3-464, Toronto, Ontario, Canada M5G 2C4. Address e-mail to davy.cheng{at}uhn.on.ca

Atrial fibrillation after coronary bypass (CABG) surgery is an important cause of morbidity and increased resource utilization. Insulin-enhanced cardioplegia may reduce postoperative arrhythmias by improving aerobic myocardial metabolism and mitigating the deleterious effects of ischemia. We performed a double-blinded, randomized, controlled clinical trial to determine if insulin-enhanced cardioplegia decreases the risk of post-CABG atrial fibrillation in a high-risk patient population. We randomized 501 patients undergoing urgent CABG to receive insulin-enhanced (Humulin R 10 IU/L, Insulin group, n = 243) or standard (Control group, n = 258) blood cardioplegia during cardiopulmonary bypass. Patients were monitored by using continuous electrocardiography for a minimum of 3 days postoperatively. All standard cardiac medications, including ß-adrenergic blockers, were continued postoperatively. Insulin-enhanced cardioplegia did not result in a significant reduction in postoperative atrial fibrillation. Furthermore, we failed to detect a difference in the incidence of conduction defects, ventricular tachycardia, or pacemaker requirements between insulin and placebo patients. Atrial fibrillation was the most common arrhythmia, occurring in 31% of all patients. Independent predictors of atrial fibrillation were elderly age, preoperative atrial fibrillation, and renal insufficiency. Right bundle branch block was the most common conduction abnormality. Predictors of right bundle branch block were elderly age, female sex, and circumflex coronary artery disease. The incidence of postoperative ventricular tachycardia, left bundle branch block, and permanent pacemaker requirement was small. We conclude that insulin-enhanced cardioplegia does not reduce the incidence of postoperative atrial fibrillation in high-risk CABG patients.

Implications: We conducted a double-blinded, randomized, placebo-controlled trial of insulin-enhanced cardioplegia in 501 patients undergoing urgent coronary bypass surgery. Insulin did not decrease the incidence of postoperative atrial fibrillation when compared with placebo. We also failed to demonstrate a difference in the incidence of other postoperative arrhythmias between the two groups of patients.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. D. Schipke, R. Friebe, and E. Gams
Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. L. Creswell, J. C. Alexander Jr., T. B. Ferguson Jr., A. Lisbon, and L. A. Fleisher
Intraoperative Interventions: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 28S - 35S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 39S - 47S.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Ovrum, G. Tangen, S. Tollofsrud, R. Oystese, M. A. L. Ringdal, and R. Istad
Cold blood cardioplegia versus cold crystalloid cardioplegia: A prospective randomized study of 1440 patients undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst
Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis
Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. Bainbridge and D. Cheng
Initial Perioperative Care of the Cardiac Surgical Patient
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 229 - 236.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Rao, G. T. Christakis, R. D. Weisel, J. Ivanov, M. A. Borger, and G. Cohen
The Insulin Cardioplegia Trial: Myocardial protection for urgent coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 928 - 935.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Korvald, O. P. Elvenes, T. Myrmel, and D. G. Sorlie
Cardiac dysfunction and inefficiency after substrate-enriched warm blood cardioplegia
Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 555 - 564.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.